Process Validation & Ongoing Process Verification

Continued Process Verification CPV Essentials For FDA EMA and MHRA Compliance

Continued Process Verification CPV Essentials For FDA EMA and MHRA Compliance Continued Process Verification CPV Essentials For FDA EMA and MHRA Compliance In the highly regulated pharmaceutical landscape, continued process verification (CPV) serves as a cornerstone of quality assurance and compliance. As outlined in guidance documents from regulatory bodies such as the FDA, EMA, and MHRA, CPV encompasses a collection…

Continue Reading Continued Process Verification CPV Essentials For FDA EMA and MHRA Compliance

Linking CPV with Annual Product Review APR and Product Quality Review PQR

Linking CPV with Annual Product Review APR and Product Quality Review PQR Introduction to CPV, APR, and PQR In the pharmaceutical industry, compliance with regulatory expectations is crucial for the manufacture of safe and effective products. Key components in this compliance framework are Continued Process Verification (CPV), Annual Product Review (APR), and Product Quality Review (PQR). These processes are designed…

Continue Reading Linking CPV with Annual Product Review APR and Product Quality Review PQR

Statistical Tools for CPV Control Charts Capability Indices and OOT Detection

Statistical Tools for CPV Control Charts Capability Indices and OOT Detection Statistical Tools for CPV Control Charts Capability Indices and OOT Detection Understanding Ongoing Process Verification (CPV) Ongoing Process Verification (CPV) represents a critical component of the pharmaceutical quality management framework, emphasizing the continuous monitoring of manufacturing processes. It aligns tightly with regulatory expectations outlined in guidelines such as FDA’s…

Continue Reading Statistical Tools for CPV Control Charts Capability Indices and OOT Detection

Data Integrity Considerations in CPV and APR Trending Programs

Data Integrity Considerations in CPV and APR Trending Programs Data Integrity Considerations in CPV and APR Trending Programs The integrity of data in pharmaceutical manufacturing is pivotal in ensuring product quality and compliance with regulatory requirements. Ongoing Process Verification (CPV) and Annual Product Reviews (APR) are crucial for maintaining the quality and compliance of pharmaceutical products. This article discusses regulatory…

Continue Reading Data Integrity Considerations in CPV and APR Trending Programs

Triggering Investigations and CAPA from CPV and APR Trending Signals

Triggering Investigations and CAPA from CPV and APR Trending Signals Continued Process Verification (CPV) is a vital component of modern pharmaceutical quality management systems, supported strongly by guidelines from regulatory authorities such as the US FDA, EMA, and PIC/S. As part of a robust quality assurance framework, CPV involves the ongoing monitoring and evaluation of processes to ensure consistent product…

Continue Reading Triggering Investigations and CAPA from CPV and APR Trending Signals

Building Dashboards and Visualisations For CPV and APR Review Meetings

Building Dashboards and Visualisations For CPV and APR Review Meetings Building Dashboards and Visualisations For CPV and APR Review Meetings Introduction to Continued Process Verification (CPV) and Annual Product Reviews (APR) Continued Process Verification (CPV) is a component of the lifecycle approach to pharmaceutical quality management that involves ongoing monitoring and evaluation of manufacturing processes throughout the product lifecycle. It…

Continue Reading Building Dashboards and Visualisations For CPV and APR Review Meetings

CPV for Biologics and Complex Modalities Special Challenges and Opportunities

CPV for Biologics and Complex Modalities Special Challenges and Opportunities CPV for Biologics and Complex Modalities Special Challenges and Opportunities Continued Process Verification (CPV) represents a crucial element in the realm of process validation, particularly for biologics and advanced therapy medicinal products (ATMPs). As pharmaceutical and regulatory professionals navigate the intricate landscape of process validation, understanding the regulatory expectations from…

Continue Reading CPV for Biologics and Complex Modalities Special Challenges and Opportunities

Selecting Critical Parameters and Attributes for CPV Monitoring

Selecting Critical Parameters and Attributes for CPV Monitoring Selecting Critical Parameters and Attributes for CPV Monitoring Continued Process Verification (CPV) is an essential component of Quality by Design (QbD) and is mandated by regulatory authorities such as the US FDA, EMA, and MHRA. This process involves the continuous monitoring of critical parameters and attributes (CQA) of a manufacturing process to…

Continue Reading Selecting Critical Parameters and Attributes for CPV Monitoring

CPV Program Governance Roles Responsibilities and Escalation Pathways

CPV Program Governance Roles Responsibilities and Escalation Pathways CPV Program Governance Roles Responsibilities and Escalation Pathways Introduction to CPV Governance Ongoing Process Verification (CPV) forms a critical component of the Quality by Design (QbD) framework, providing a structured approach for pharmaceutical manufacturers to ensure that processes remain in a state of control. The US FDA’s guidance on process validation, alongside…

Continue Reading CPV Program Governance Roles Responsibilities and Escalation Pathways

CPV in Continuous Manufacturing Real Time Data and Advanced Analytics

CPV in Continuous Manufacturing Real Time Data and Advanced Analytics Introduction to Continual Process Verification (CPV) Continual Process Verification (CPV) represents a fundamental shift in the way pharmaceutical manufacturing processes are validated and monitored. Under current regulatory frameworks, including US FDA’s Process Validation Guidance from 2011, CPV emphasizes ongoing verification of processes in real time, especially in the context of…

Continue Reading CPV in Continuous Manufacturing Real Time Data and Advanced Analytics